Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Miragen Therapeutics Inc (MGEN)

Miragen Therapeutics Inc (MGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Miragen Therapeutics Inc 6200 LOOKOUT ROAD BOULDER CO 80301 USA

www.signalgenetics.com P: 720-643-5200

Description:

Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 89,928
Shares Outstanding, K 3,908
Annual Sales, $ 4,460 K
Annual Net Income, $ -41,870 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,490 K
60-Month Beta 1.66
% of Insider Shareholders 1.10%
Float, K 3,865
% Float 98.90%

Growth:

1-Year Return 132.42%
3-Year Return -82.12%
5-Year Return -81.41%
5-Year Revenue Growth 3.24%
5-Year Earnings Growth 97.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/10/21
Earnings Per Share ttm -10.65
EPS Growth vs. Prev Qtr 16.66%
EPS Growth vs. Prev Year 72.22%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 11/13/20

MGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -141.66%
Return-on-Assets % -88.74%
Profit Margin % -938.79%
Debt/Equity 0.20
Price/Sales 47.83
Price/Cash Flow N/A
Price/Book 4.16
Book Value/Share 5.52
Interest Coverage -48.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar